Trauma Clinical Trial
Official title:
Using a Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women
Verified date | September 2021 |
Source | University of Iceland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This research study is an extension on a study already preregistered NCT04209283 and is designed to investigate the use of a simple cognitive task (a memory cue followed by playing the computer game "Tetris") for decreasing the number of intrusive memories of trauma among trauma-exposed women in Iceland. This is a single case series using a within subject multiple baseline AB design. Participants will aim to complete a no-intervention phase ('A': baseline phase) of one week followed by a one-week intervention phase ('B'), including a one-session intervention with a researcher comprising the simple cognitive task, followed by instructions to continue using the technique self-guided in subsequent weeks. Participants will be asked to monitor the occurrence of intrusive memories of trauma in a daily diary. It is predicted that participants will report fewer intrusive memories during the intervention phase than during the preceding baseline phase and that the frequency of targeted intrusive memories is going to decrease relative to non-targeted intrusive memories. Furthermore, the investigators will explore whether having fewer intrusive memories has an impact on function and/or PTSD, depressive or anxiety symptoms.
Status | Completed |
Enrollment | 10 |
Est. completion date | September 1, 2021 |
Est. primary completion date | September 1, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 69 Years |
Eligibility | Inclusion Criteria: - Having experienced at least one criterion A trauma according to the DSM-5 - Having at least one intrusive memory that occurs at least three times per week in the past four weeks - Being able to attend 3-8 sessions with researcher - Being willing to monitor intrusive memories in daily life - Having access to a smartphone - Being able to speak Icelandic and read study materials in Icelandic Exclusion Criteria: - Current psychotic disorder (determined by the psychotic module on the Mini International Neuropsychiatric Interview (MINI)). - Current manic episode (determined by the bipolar module on the Mini International Neuropsychiatric Interview (MINI)). - Being acutely suicidal (according to the module assessing suicidality on the Mini International Neuropsychiatric Interview (MINI)). |
Country | Name | City | State |
---|---|---|---|
Iceland | University of Iceland | Reykjavík |
Lead Sponsor | Collaborator |
---|---|
University of Iceland |
Iceland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in the number of intrusive memories of trauma | Number of intrusive memories of traumatic event recorded by participants in a diary daily (morning, afternoon, evening and night) for one week during the baseline phase and each week during the intervention phase (week 1-6) and during one week at one month follow-up and three month follow-up. | Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up | |
Secondary | Self-guided intervention adherence - usage of the gameplay intervention in daily life | How often did you manage to play Tetris after you experienced an intrusive memory? (11-point scale; 0 = not at all; 10 = every time). | Intervention week 2-6 | |
Secondary | Feasibility and acceptability ratings for using a smartphone game-play intervention | Feasibility and Acceptability of the intervention assessed with two self-rated items, "Would you recommend playing Tetris to a friend?" and "Do you consider gameplay to be an acceptable way to reduce the daily frequency of intrusive memories?". Scores could range from 0 - 10 with higher scores indicating greater acceptability/feasibility. | Post intervention up to week 7 | |
Secondary | Feasibility and acceptability - open ended questions | Two open-ended questions: 1. "How did you feel about playing Tetris after you had an intrusive memory?" 2. "Did you find the intervention helpful? If yes, how?" | Post intervention up to week 7 | |
Secondary | Impact of intrusive memories on concentration, sleep and stress - ratings | Six self-rated items to assess the impact of intrusive memories on concentration, sleep, and stress in the past week. 2 items assessing concentration difficulties in general and due to intrusive memories (11-point scale; high scores indicating more difficulties). 2 items assessing sleep disturbances due to intrusive memories (11-point scale; higher scores indicating more sleep disturbance); and 1 item assessing to what degree intrusive memories affected stress levels (0 = not at all; 10 = affected very much). | Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up | |
Secondary | Rating of how long intrusive memories disrupted concentration on average | 1 item assessing for how long intrusive memories disrupted concentration on average on a 6-point scale (0 = <1 minute - 6 = > 60 minutes) | Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up | |
Secondary | General impact of intrusive memories - ratings | Two items both rated on an 11-point scale: 1. "During the last week, how distressing were your intrusive memories (0 = not at all; 10 = very distressing). 2. During the last week, how vivid were your intrusive memories (0 = not at all; 10= very vivid) | Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up | |
Secondary | Intrusion diary adherence | Adherence to the intrusion diary assessed with 1 item: "How accurately did you fill out the diary?" (0= not at all; 10 = very accurately) | Baseline phase week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up | |
Secondary | The Posttraumatic Stress Disorder Checklist 5 (PCL-5) | The PCL-5 is a short 20-item self-report scale used to assess the severity of PTSD symptoms corresponding to the DSM-5 criteria for PTSD. Symptoms are rated from 0-4. Higher scores indicate greater severity. | Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up | |
Secondary | The Patient Health Questionnaire-9 (PHQ-9) | The PHQ-9 is a 9-item self-report measure of depression symptoms and the severity of those symptoms. Each item can be scored from 0 (i.e., not at all) to 3 (i.e., nearly every day). | Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up | |
Secondary | The Generalized Anxiety Disorder-7 scale (GAD-7) | The GAD-7 is a brief self-report questionnaire designed as a screening tool for symptoms of general anxiety disorder and their severity. Each item can be scored from 0 (i.e., not at all) to 3 (i.e., nearly every day). | Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up | |
Secondary | The Sheehan Disability Scale (SDS) | The SDS is a self-report questionnaire which is designed to assess functional impairment across three domains: (1) Work/school, (2) social, and (3) family life. These domains are measured on an 11-point scale which ranges from 0 (i.e., not at all) to 10 (i.e., extremely). The scale will be adjusted to assess impairment associated with intrusive memories. | Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up | |
Secondary | Impact of intrusive memories on functioning | Two questions assessing the impact intrusive memories have on functioning in daily life. One question is open-ended: "Have the intrusive memories affected your ability to function in your daily life in the past week? If yes, how?" and one question is self-rated: "Have the intrusive memories affected your ability to function in your daily life?" (11-point scale, higher score indicate greater impact on functioning.) | Baseline week 1; Post intervention up to week 7, 1 month follow-up and 3 month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848376 -
Post-Market Clinical Follow-up Study of A-SPINE's Products
|
||
Terminated |
NCT03781817 -
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
|
Phase 4 | |
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Completed |
NCT04356963 -
Adjunct VR Pain Management in Acute Brain Injury
|
N/A | |
Completed |
NCT05669313 -
The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
|
||
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Recruiting |
NCT04725721 -
Testing FIRST in Youth Outpatient Psychotherapy
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Not yet recruiting |
NCT03696563 -
FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS
|
N/A | |
Withdrawn |
NCT03249129 -
Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
|
||
Completed |
NCT02240732 -
Surgical Tourniquets and Cerebral Emboli
|
N/A | |
Completed |
NCT02227979 -
Effects of PURPLE Cry Intervention
|
N/A | |
Withdrawn |
NCT01169025 -
Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01475344 -
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
|
Phase 1/Phase 2 | |
Completed |
NCT03112304 -
Child STEPS for Youth Mental Health in Maine Sustainability
|
N/A | |
Completed |
NCT01210417 -
Trauma Heart to Arm Time
|
N/A | |
Completed |
NCT01201863 -
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
|
Phase 4 | |
Completed |
NCT01426711 -
Critical Care Excellence in Sepsis and Trauma
|